Imran, Khan MohammadTintera, BenjaminMorrison, Holly A.Tupik, Juselyn D.Nagai-Singer, Margaret A.Ivester, HannahCouncil-Troche, McAlisterEdwards, MichaelCoutermarsh-Ott, SherylByron, ChristopherClark-Deener, SherrieUh, KyungjunLee, KihoBoulos, PaulRowe, CliffCoviello, ChristianAllen, Irving C.2023-06-272023-06-272023-05-24Imran, K.M.; Tintera, B.; Morrison, H.A.; Tupik, J.D.; Nagai-Singer, M.A.; Ivester, H.; Council-Troche, M.; Edwards, M.; Coutermarsh-Ott, S.; Byron, C.; Clark-Deener, S.; Uh, K.; Lee, K.; Boulos, P.; Rowe, C.; Coviello, C.; Allen, I.C. Improved Therapeutic Delivery Targeting Clinically Relevant Orthotopic Human Pancreatic Tumors Engrafted in Immunocompromised Pigs Using Ultrasound-Induced Cavitation: A Pilot Study. Pharmaceutics 2023, 15, 1585.http://hdl.handle.net/10919/115523Pancreatic tumors can be resistant to drug penetration due to high interstitial fluid pressure, dense stroma, and disarrayed vasculature. Ultrasound-induced cavitation is an emerging technology that may overcome many of these limitations. Low-intensity ultrasound, coupled with co-administered cavitation nuclei consisting of gas-stabilizing sub-micron scale SonoTran Particles, is effective at increasing therapeutic antibody delivery to xenograft flank tumors in mouse models. Here, we sought to evaluate the effectiveness of this approach in situ using a large animal model that mimics human pancreatic cancer patients. Immunocompromised pigs were surgically engrafted with human Panc-1 pancreatic ductal adenocarcinoma (PDAC) tumors in targeted regions of the pancreas. These tumors were found to recapitulate many features of human PDAC tumors. Animals were intravenously injected with the common cancer therapeutics Cetuximab, gemcitabine, and paclitaxel, followed by infusion with SonoTran Particles. Select tumors in each animal were targeted with focused ultrasound to induce cavitation. Cavitation increased the intra-tumor concentrations of Cetuximab, gemcitabine, and paclitaxel by 477%, 148%, and 193%, respectively, compared to tumors that were not targeted with ultrasound in the same animals. Together, these data show that ultrasound-mediated cavitation, when delivered in combination with gas-entrapping particles, improves therapeutic delivery in pancreatic tumors under clinically relevant conditions.application/pdfenCreative Commons Attribution 4.0 Internationalpancreatic cancerpaclitaxelgemcitabinecetuximabdrug deliverySonoTran Particlessonoporationpassive acoustic mappinglarge animal cancer modelfocused ultrasoundArticle - Refereed2023-06-27https://doi.org/10.3390/pharmaceutics15061585